This approach highlights the novelty of our microfilter-based delivery system in advancing placental research and addressing reproductive disorders, as well as the therapeutic potential of MSC-sEVs and FKBPL-relevant mechanisms for managing preeclampsia-associated dysfunction. This evidence concerns the gene FKBPL and preeclampsia.